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a b s t r a c t
Background: Diabetes is a metabolic disorder characterized by enhanced production of free
radicals hence oxidative stress. The aim of this study was to evaluate the activity of cardiac
and antioxidant enzymes in diabetic and non-diabetic acute myocardial infarction (AMI)
patients.
Methods: This case–control study was conducted on 450 subjects (70–85 years). Subjects were
divided into three groups (Normal, N; Non-diabetic AMI, N-AMI; and Diabetic AMI, D-AMI).
Each individual was subjected to a detailed history, clinical examination, and cardiovascular
parameters analysis (fasting blood sugar, HbA1c, systolic and diasystolic blood pressure,
total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), high-density lipopro-
tein (HDL), TC/HDL and LDL/HDL ratios). Cardiac markers (Troponin-I, creatine phosphoki-
nase (CPK), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), C-reactive protein
(CRP) and aspartate aminotransferase (AST)) and oxidative stress markers (superoxide
dismutase (SOD), malondialdehyde (MDA), glutathione (GSH), catalase (CAT)) were also
assessed. All these parameters were compared between diabetic and non-diabetic AMI
patients.
Results: D-AMI individuals had high level of TC, TG, LDL, and low level of HDL in comparison
to N-AMI individuals. Study suggests that cardiac markers such as Troponin I, CPK, CK-MB,
AST, LDH, and CRP levels were signiﬁcantly increased in patients suffering from myocardial
infarction with diabetes mellitus (DM) compared to patients of myocardial infarction
without DM. The activity levels of antioxidant SOD and GSH were lower in D-AMI patients
than in N-AMI. However, levels of MDA and CAT were higher in D-AMI than in N-AMI
controls.
Conclusion: Study suggests elevated cardiac markers and reduced antioxidants in D-AMI
patients compared to N-AMI patients.
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Diabetes mellitus (DM) increases the incidence of cardiovas-
cular diseases (CVDs) and increases the risk of CVD-induced
mortality in diabetic subjects compared to non-diabetic
subjects.1,2 Coronary artery disease (CAD) contributed to
myocardial infarction (MI) and heart failure, attributed to
most of the mortalities around the globe.3–5 Acute myocardial
infarction (AMI) is associated with obstruction of coronary
artery, myocardial ischemia leading to myocardial necrosis
and generation of reactive oxygen species (ROS).6 Previous
studies show that hyperglycemia promotes ROS-induced
complications of heart by reacting with lipids, protein, and
DNA7; this oxidative damage is rescued by myocardial
antioxidants.8 Several studies depicted that antioxidants
functioning is diminished in diabetic subjects,9 which may
further augment the oxidative stress-induced pathogenesis of
AMI.10 Diabetes, dyslipidemia, hypertension, family history,
obesity, and smoking are well documented risk factors for the
development of AMI.11
The purpose of the study was to assess the oxidative stress-
induced damage to heart in diabetic and non-diabetic AMI
patients. This study emphasizes that antioxidants imbalance
may be a key indicator of diabetes-induced myocardial
damage as other indicators such as ECG and cardiac
biomarkers. The data showed signiﬁcant increase in lipid
parameters (total cholesterol (TC), triglycerides (TG), high-
density lipoprotein (HDL), low-density lipoprotein (LDL), and
cardiac markers, i.e. troponin-I (TnI), creatine phosphokinase
(CPK), creatine kinase-MB (CK-MB), lactate dehydrogenase
(LDH), aspartate aminotransferase (AST), C-reactive protein
(CRP) within 12 h after the onset of chest pain in D-AMI
patients compared to N-AMI patients. Oxidative stress
markers such as malondialdehyde (MDA), catalase (CAT),
superoxide dismutase (SOD), and glutathione (GSH) also
increased in D-AMI patients compared to N-AMI patients.
Study results suggest that antioxidants based interventions in
D-AMI patients might assist to reduce oxidative stress-
induced damage in D-AMI patients.
2. Methods
2.1. Subjects and study design
This case–control study included 450 subjects; out of which,
150 subjects (90 males and 60 females) were with normal blood
glucose level and with normal ECG (Normal, N), 150 subjects
(85 males and 65 females) were with normal blood glucose
level and AMI (non-diabetic and AMI, N-AMI), and 150 subjects
(98 males and 52 females) were with diabetes and AMI
(Diabetic and AMI, D-AMI), visiting the outpatient clinic at
Department of Cardiology at Services Hospital Lahore, Punjab
Institute of Cardiology Lahore and Ittefaq Hospital Lahore,
Pakistan from September 2013 to May 2014.
Diabetes was diagnosed by analyzing the level of glycated
hemoglobin level (HbA1c > 6.5%).12 Diagnosed cases of diabet-
ic and non-diabetic AMI patients were included after obtaining
a written consent from their caretakers to take part in thestudy. Questionnaires were duly ﬁlled in with bio-data of the
patients, detailed medical history, blood pressure, electrocar-
diography (ECG), complete blood count (CBC) along with
available additional information. This study was approved
by the local ethical committee at The University of Lahore,
Pakistan.
2.2. Inclusion criteria and exclusion criteria
Subjects of all ages and both genders with the history of AMI
were included. AMI diagnosis was based on a history of chest
pain, ECG changes, and elevated cardiac enzymes.6,13 Diabetic
and non-diabetic AMI patients were included in this study. The
control subjects were selected on basis of being normotensive
and with normal ECG. Subjects who have the history of
smoking, obesity, or any other disease were excluded from this
study.
2.3. Collection of blood and isolation of serum
Blood samples were collected from Department of Cardiology
at Services Hospital Lahore, Punjab Institute of Cardiology
Lahore and Ittefaq Hospital Lahore. Preprandial venous blood
were drawn from cubital vein from all subjects and instantly
transferred from hospital to CRIMM laboratory in an icebox.
Blood samples were centrifuged at 2000  g for 10 min at 4 8C.
Serum was aspirated, aliquoted, and stored at 20 8C for
analysis.
2.4. Evaluation of cardiovascular parameters
Serum levels of TC, TG, and HDL were measured spectropho-
tometrically using commercial assay kits (Randox laboratories
Ltd, United Kingdom). LDL was calculated by using Friedewald
formula.14
2.5. Analysis of cardiac markers
Levels of various cardiac enzymes including troponin-I (TnI),
CPK, CK-MB, LDH, AST, and CRP were assessed using
commercial kits (Randox laboratories Ltd, United Kingdom).
2.6. Estimation of oxidative stress
Oxidative stress was measured by analyzing the serum level of
MDA, CAT, SOD, and GSH at Institute of Molecular Biology and
Biotechnology (IMBB), The University of Lahore.
2.7. Determination of SOD activity
SOD activity was determined by the method of Kakkar et al.15
Homogenate was prepared by mixing serum and trichloroa-
cetic acid (50%) in 1:1 ratio and centrifuged at 13,000 rpm for
10 min at 25 8C. 15 mL supernatant was added to 120 mL sodium
pyrophosphate buffer (52 mM, pH 8.3), 12 mL phenazine
methosulphate, 36 mL nitroblue tetrazolium. Reaction was
started by addition of 24 mL nicotinamide adenine dinucleo-
tide. After incubation at 37 8C for 90 s, reaction was stopped by
addition of 12 mL of glacial acetic acid. The reaction mixture
was stirred vigorously with 400 mL of n-butanol. The mixture
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5 min at 25 8C and butanol layer was separated. The color
intensity of chromogen in butanol layer was measured at
560 nm against n-butanol using a spectrophotometer.
2.8. Estimation of GSH
Reduced GSH was assayed according to method of Beutler
et al.16 Homogenate was prepared by mixing serum and
trichloroacetic acid (10%) in 1:1 ratio and centrifuged at
1000 rpm for 10 min at 25 8C. 40 mL supernatant was mixed
with 150 mL of 0.3 M disodium phosphate buffer. Then 25 mL of
0.001 M freshly prepared DTNB [5,50-dithiobis (2-nitrobenzoic
acid) dissolved in 1% sodium citrate] was added. Reduction of
DTNB with GSH produces a yellow compound, whose absor-
bance was noted spectrophotometrically at 412 nm. The
reduced chromogen is directly proportional to GSH concen-
tration.
2.9. Estimation of CAT activity
Activity of CAT was monitored by using method described by
Sinha.17 40 mL serum was mixed with 360 mL phosphate buffer
(10 mM, pH 7.0) and centrifuged at 13,000 rpm for 10 min at
25 8C. 21 mL of the supernatant and 180 mL phosphate buffer
(10 mM, pH 7.4) were added in an eppendorf. Reaction was
started by addition of freshly prepared 75 mL H2O2 (0.2 M).
360 mL potassium dichromate acetic acid reagent (5%) was
added to reaction mixture and incubated for 10 min in boiling
water, cooled, and absorbance was measured at 530 nm.
2.10. Estimation of MDA level
Level of MDA, a free radical species, was evaluated by
measuring thiobarbituric acid (TBA) reactive substances via
method of Ohkawa et al.18 For this, 40 mL of serum was taken
and a homogenate was prepared in 360 ml phosphate buffers
(10 mM, pH 7.4) and centrifuged at 13,000 rpm for 10 min at
25 8C. 15 mL supernatant was mixed with 15 mL SDS (8.1%),
96 mL TBA (0.8%), 96 mL acetic acid (20%) and 18 mL distilled
water and incubated at 90 8C for 60 min. Afterwards, 60 mL
distilled water and 300 mL n-butanol-pyridine mixture (15:1)
was added and the mixture was shaken vigorously andTable 1 – General demographic characteristics.
Characteristics N group (150 subjects) N-AMI group (1
Male/Female (n) 90/60 85/65 
Age (years) 80.0  10.1 80.2  1
FBG (mm/L) 43  0.6 5.2  0.
HbA1c (%) 3.5  1.2 5.8  2.
SBP (mm Hg) 122  10 133  2
DBP (mm Hg) 80  9 84  14
All values are mean  SD.
* p value for D-AMI versus N-AMI.
# p for D-AMI versus N group.
a p for N-AMI versus N group.
D-AMI, diabetic and myocardial infarction; DBP, diasystolic pressure; FBG
AMI, non-diabetic and myocardial infarction; SBP, systolic pressure.centrifuged at 4000 rpm at 25 8C for 10 min. The upper butanol
layer was separated and its absorbance was taken at 532 nm.
2.11. Statistical analysis
Statistical analysis was performed using GraphPad Prism
version 5.00 for Windows (GraphPad Software, San Diego, CA,
USA). At ﬁrst one-way ANOVA was used to compare
quantitative variables between three groups and then Bon-
ferroni post hoc test was used to conﬁrm where the differences
occurred between groups. All data were presented as mean
 standard deviation (SD). p < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Demographic characteristics of subjects
Study subjects were divided on the basis of health conditions
into N group, normal (150 subjects); N-AMI group, non-diabetic
with AMI (150 subjects); and D-AMI group, diabetic with AMI
(150 subjects). N-AMI patients had mean age of 80.2  19.0
years, whereas D-AMI patients had mean age 70.2  11.4 years.
Systolic blood pressure (SBP) and diasystolic pressure (DBP)
were high in D-AMI and N-AMI compared with normal group.
Fasting blood glucose (FBG) and HbA1c levels were signiﬁcant-
ly high in D-AMI group (p < 0.001) compared with N-AMI and
normal group. Results of basic demographic characteristics are
illustrated in Table 1.
3.2. Evaluation of cardiovascular parameters
Alterations in levels of all the lipid constituents among all
groups are presented in Fig. 1. D-AMI group showed signiﬁcant
increase in TC (270.3  12.4 mg/dL), TG (301.3  18.5 mg/dL),
LDL (291.7  22.4 mg/dL) levels compared to that of N-AMI
group for TC (238.2  10.4 mg/dL), TG (229.2  23.3 mg/dL), LDL
(247.7  24.2 mg/dL) and N group for TC (181.2  14.2 mg/dL),
TG (151.0  29.0 mg/dL), LDL (139.0  13.0 mg/dL), respectively
(Fig. 1A–C). Whereas, D-AMI group showed signiﬁcantly lower
level of HDL (26.3  7.0 mg/dL) in comparison to N-AMI group
(31.5  1.9 mg/dL) and N group (40.3  5.2 mg/dL), respectively50 subjects) D-AMI group (150 subjects) p-Value
98/52 –
8.9 70.2  11.4 <0.001*,#
8 8.7  1.6 <0.001*,#,a
7 9.6  1.9 <0.001*,#,a
4 160  22 <0.001*,#,a
 93  20 <0.001*,#,a
, fasting blood glucose; HbA1c, glycated hemoglobin; N, normal; N-
Fig. 1 – Evaluation of cardiovascular parameters. (A) Total cholesterol (TC), (B) triglycerides (TG), (C) low-density lipoproteins
(LDL), (D) high-density lipoproteins (HDL), (E) TC/HDL ratio, and (F) LDL/HDL ratio. All value were expressed as mean W SD. D-
AMI versus N-AMI, *p < 0.05; D-AMI versus N group, #p < 0.05; N-AMI versus N group, and ap < 0.05.
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and LDL/HDL ratios compared to N-AMI (Fig. 1E and F).
3.3. Evaluation of cardiac markers
D-AMI patients had signiﬁcantly higher level of CRP (7.8
 0.3 mg/L) as compared to N-AMI (4.4  0.6 mg/L) patients
(Fig. 2A).
TnI level was also found signiﬁcantly high in D-AMI patient
(3.3  0.2 ng/mL) than N-AMI group (1.8  0.2 ng/mL). The data
demonstrated signiﬁcant elevations of CPK (1075.0  28.4 IU/L)
and CK-MB (235.3  16.2 IU/L) in D-AMI patients compared to
N-AMI for CPK and CK-MB (324.2  18.3 IU/L) (104.7  5.0 IU/L)
(Fig. 2B–D).
Level of LDH was found to be elevated in serum of D-AMI
(1004.0  30.1 IU/L) compared to N-AMI (615.0  105.1 IU/L).
Similar to LDH, D-AMI patients showed signiﬁcant elevations
of AST (102.0  3.6 IU/L) compared to those of N-AMI patients
(62.3  14.6 IU/L) (Fig. 2E and F).
3.4. Assessment of oxidative stress markers
Oxidative stress induced in AMI was measured by evaluating
levels of MDA, SOD, GSH, and CAT. There was an increase in
MDA level (0.09  0.0) and CAT activity (0.60  0.1) in D-AMI
group compared to N-AMI group for MDA (0.05  0.0) and CAT
(0.90  0.0) (Fig. 3A and B). Compared with N-AMI group, SOD
activity (0.07  0.0), and GSH level (0.07  0.0) were decreasedin D-AMI group for SOD (0.05  0.0) and GSH (0.05  0.0),
respectively (Fig. 3C and D).
4. Discussion
AMI is initiated by myocardial ischemia due to enhanced
production of ROS,10 activation of proinﬂammatory reac-
tions,19 impaired functioning of antioxidants,20 and increased
lipid peroxidation.21 All these events elicit the activation of
plaque, coronary blockage and ultimately heart attack. The
large segment of Pakistani population suffer from AMI.22,23
There are numerous risk factors associated with the develop-
ment of AMI, such as diabetes, dyslipidemia, hypertension,
smoking, obesity, advancing age, etc.6 Bartels et al.24 reported
that diabetes increases the risk of CVD in diabetic subjects
compared with non-diabetic subjects. The present study,
presented the effect of hypertension, diabetes, and dyslipide-
mia in D-AMI patients. Type 2 diabetes was found to alter
lipids and lipoproteins utilization and induce atherogenic
dyslipidemia.25,26 Our results show signiﬁcantly higher levels
of TC, TG, and LDL however; low level of HDL in D-AMI
patients, and this suggests an important role of atherogenic
dyslipidemia in the development of AMI in diabetic subjects.
Atherogenic dyslipidemia favors the oxidative modiﬁcation
of proteins along with lipids specially LDL and thus induces a
local and systemic inﬂammatory responses.27,28 These in-
ﬂammatory responses trigger myocardial tissue injury which
Fig. 3 – Assessment of oxidative stress markers. (A) Lipid peroxidation was assessed by measuring Malondialdehyde (MDA)
generation in groups, (B) catalase (CAT), (C) superoxide dismutase (SOD), and (D) reduced glutathione (GSH). All values were
expressed as mean W SD. D-AMI versus N-AMI, *p < 0.05; D-AMI versus N group, #p < 0.05; N-AMI versus N group, ap < 0.05.
Fig. 2 – Evaluation of cardiac markers. (A) C-reactive protein (CRP), (B) troponin-I (TnI), (C) creatine phosphokinase (CPK), (D)
creatine kinase-MB (CK-MB), (E) lactate dehydrogenase (LDH), and (F) aspartate aminotransferase (AST). All values were
expressed as mean W SD. D-AMI versus N-AMI, *p < 0.05; D-AMI versus N group, #p < 0.05; N-AMI versus N group, ap < 0.05.
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i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 3 2 5 – 3 3 1330is detected by measuring the CRP level. Indeed, CRP is systemic
inﬂammation marker and gives prognostic information of
cardiovascular events such as atherosclerosis and CAD.29,30 In
this study, increased CRP was found in D-AMI patients
compared to N-AMI.
Heart contractility is evaluated by measuring the myocar-
dial tissue speciﬁc protein Trop I, involved in cardiac
contractility. Previous studies indicated that Trop I is highly
sensitive and speciﬁc marker of myocardial damage and
therefore used as a diagnostic marker for AMI.31 In this study,
signiﬁcantly raised level of Trop I was found in D-AMI patients
compared to N-AMI patients indicating that cardiac muscle
cell death increases in diabetic subjects.
CPK and CK-MB are two important indicators of myocardial
necrosis32 and a signiﬁcant elevation of CPK and CK-MB was
documented in D-AMI group in this study. We also found
statistically signiﬁcant difference in LDH and AST values
between D-AMI and N-AMI groups, the two markers being
advocated for diagnosis of infarct previously.33
Hyperlipidemia and hyperglycemia-induced oxidative stress
has been regarded as contributors to progression of AMI.2 The
oxidative stress results in disturbance between free radicals and
antioxidant defense mechanism. SOD, one of the important
defense enzymes catalyzes the dismutation of superoxide
radicals into either oxygen (O2) or hydrogen peroxide (H2O2).
31
Glutathione peroxidase (GPX) or CAT catalyzes the reduction of
H2O2 into H2O, CAT catalyzes this reduction independently
without any cofactor, whereas GPX relies on GSH,34 GSH also
inhibits lipid peroxidation.35 Previous reports showed that lipid
peroxidation increased in AMI patients,36 and this increased
lipid peroxidation is a consequence of hyperglycemia-induced
oxidative stress. This study revealed signiﬁcant decrease in
antioxidants including SOD, GSH, and CAT, and an increase in
MDA, which is lipid peroxidation product in D-AMI patients
compared to N-AMI patients.
Our study indicates the signiﬁcance of atherosclerosis and
its associated complications such as dyslipidemia and
inﬂammation in D-AMI patients. In conclusion, our study
demonstrates a signiﬁcant increase in traditional cardiac
markers (CPK, CK-MB, LDH, and AST) and non-traditional
cardiac markers such as CRP in D-AMI patients compared to N-
AMI. The study shows a signiﬁcant increase of oxidative stress
parameter MDA while levels of antioxidants CAT, SOD, and
GSH are reduced in D-AMI patients. These results will be
helpful for clinicians in therapy of MI patients with DM.
4.1. Limitation of study
Following limitation should have to be considered for interpre-
tation of the study: The data were collected in a short time
period and from a few local hospitals. We also have limited
resources for this project, so we relied on present data. Although
some similar reports have been published before, but to the best
of our knowledge it is the ﬁrst organized data of diabetic and
acute myocardial infarcted patients of local population.
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